Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Tundra lists 1 Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT02203903

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

This Phase I dose-escalation trial is designed to evaluate the safety of administering rapidly -generated tumor multi-antigen associated -specific cytotoxic T lymphocytes, to HSCT recipients with high risk AML and MDS.

Gender: All

Ages: 6 Months - 80 Years

Updated: 2025-05-31

2 states

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS